Julie Krop
Direttore/Membro del Consiglio presso AQUESTIVE THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael Parini | M | 49 | 3 anni | |
| Jeffrey Leiden | M | 68 | 15 anni | |
| Daniel Barber | M | 48 | 17 anni | |
| Bharatt Chowrira | M | 59 |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 7 anni |
| Kevin Lobo | M | 58 | 13 anni | |
| Peter Boyd | M | 58 | 11 anni | |
| Stephen M. Muniz | M | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 24 anni |
| Christopher Viehbacher | M | 64 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 9 anni |
| A. Schobel | M | 68 | 19 anni | |
| Dame Marjorie Scardino | F | 77 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 9 anni |
| David R. Elmaleh | M | 76 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 24 anni |
| Robert Langer | M | 74 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 24 anni |
| Lori Braender | F | 68 | 6 anni | |
| Douglas Lankler | M | 58 | 25 anni | |
| Santo Costa | M | 78 | 9 anni | |
| Daphne Zohar | F | 54 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 19 anni |
| Sharon Barber-Lui | F | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 2 anni |
| Gregory Brown | M | 70 | 17 anni | |
| Yin Becker | F | 60 | 12 anni | |
| Jonathan Behr | M | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Stuart Arbuckle | M | 58 | 12 anni | |
| Amit Sachdev | M | 56 | 17 anni | |
| James Bircher | M | 56 | 3 anni | |
| Cassie Jung | F | 45 | 20 anni | |
| Timothy Morris | M | 62 | 2 anni | |
| H. Robert Horvitz | M | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Marco Taglietti | M | 64 | 3 anni | |
| Francis J. Bullock | M | 87 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Eric Elenko | M | 51 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Fredrick Frank | M | 92 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| John Cochran | M | 58 | 20 anni | |
| Michael Rosenblatt | M | 76 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| David Altshuler | M | 59 | 12 anni | |
| Kiran Mazumdar-Shaw | F | 71 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Clifford J. Woolf | M | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Allan Golston | M | 57 | 13 anni | |
| John LaMattina | M | 74 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | 15 anni |
| Dennis Selkoe | M | 80 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Joseph Crusco | M | - | - | |
| Samantha Ventimiglia | F | - | 13 anni | |
| Suneet Varma | M | 55 | 23 anni | |
| Ben Shapiro | M | 84 |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Shinichiro Fuse | M | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | - |
| Jeanne Blondia | F | - | 16 anni | |
| Stephen Wargacki | M | 46 | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Frank Thomas | M | 54 | 6 anni | |
| Henry McKinnell | M | 81 | 8 anni | |
| Keith Kendall | M | 66 | 16 anni | |
| Brian Piekos | M | 49 | 5 anni | |
| Michael Hutchinson | M | 53 | - | |
| Scott A. Holmes | M | 50 | 4 anni | |
| Edward Myles | M | 52 | 4 anni | |
| Anthony Casciano | M | - | 4 anni | |
| Paul Silva | M | 58 | 14 anni | |
| TY Howton | M | 52 | 3 anni | |
| Matthew Emmens | M | 72 | - | |
| George A. Lorch | M | 82 | 15 anni | |
| Gino Santini | M | 67 | 8 anni | |
| Douglas Bratton | M | 65 | 17 anni | |
| Scott Myers | M | 57 | - | |
| William Heiden | M | 64 | 8 anni | |
| Paul R. Fonteyne | M | 62 | 1 anni | |
| Linda S. Lennox | F | 59 | 5 anni | |
| John Grotting | M | 74 | 2 anni | |
| Joe Bolen | M | 70 | 7 anni | |
| Charlie Sanders | M | 91 | 14 anni | |
| Theresa Heggie | F | 63 | 1 anni | |
| Wayne Riley | M | 64 | 5 anni | |
| Thomas G. Gant | M | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 9 anni |
| Carole Cassidy | F | - |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | 6 anni |
| Joseph Vittiglio | M | 52 | 5 anni | |
| Eugene H. Cordes | M | 87 | - | |
| Jeffrey Chodakewitz | M | 68 | 4 anni | |
| Kathryn Carr Payne | F | - | 4 anni | |
| Kathrine O'Brien | F | 61 | 1 anni | |
| John Fallon | M | 76 | 6 anni | |
| Srikant T. Madhav Datar | M | 70 | 15 anni | |
| Barbara H. Deptula | F | 69 | 7 anni | |
| Vicki Sato | M | 75 | 13 anni | |
| Robert Perez | M | 59 | 11 anni | |
| Lesley Russell | M | 63 | 10 anni | |
| Michael R. Jirousek | M | 65 | 5 anni | |
| Robert N. Burt | M | 86 | 11 anni | |
| Peter Corr | M | 76 | 6 anni | |
| James Sulat | M | 73 | 6 anni | |
| Dennis L. Winger | M | 77 | 3 anni | |
| Richard H. Aldrich | M | 69 | 12 anni | |
| Thomas Auchincloss | M | 62 | 7 anni | |
| Kevin Starr | M | 61 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 anni |
| Nancy Simonian | M | 63 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 10 anni |
| Frederic Roch Doliveux | M | 68 | 11 anni | |
| Terrence Kearney | M | 69 | 13 anni | |
| Ian Smith | M | 58 | 18 anni | |
| Katherine Owen | F | 53 | 14 anni | |
| Davey Scoon | M | 78 | 14 anni | |
| Louise Francesconi | F | 71 | 14 anni | |
| Nancy Lurker | F | 66 | 4 anni | |
| Yuchun Lee | M | 58 | 11 anni | |
| Thomas Mathers | M | 56 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | 8 anni |
| Andrés Cedrón | M | 43 | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 98 | 98.00% |
| Regno Unito | 3 | 3.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Julie Krop
- Contatti personali
